SRx Health Solutions, Inc.
For the period ended Sep 30, 2025. Filed Dec 5, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Dec 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
| ITEM 9B. | OTHER INFORMATION |
|---|
10b5-1 Plans
During the year ended September 30, 2025, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” as such term is defined in Item 408(a) of Regulation S-K. As of September 30, 2025, the Company did not have a “Rule 10b5-1 trading arrangement” in effect with respect to its securities.
Insider Trading Policy
The Company has adopted insider trading policies and procedures governing the purchase, sale, and other disposition of its securities, which has been included as an exhibit to this report and has been posted to the governance documents section of the Company’s corporate website (www.srxhealth.com).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.